B. Draznin

B. Draznin, K. Young, S. Seggelke, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Insulin Use in Hospitalized Patients With Diabetes: Navigate With Care

B. Draznin, C. Wang, 2013, Diabetes Spectrum.

Somatostatin receptors are biologically active before they are inserted into the plasma membrane.

B. Draznin, R. Robbins, A. Vatter, 1986, Endocrinology.

Internalization and cellular processing of somatostatin in primary culture of rat anterior pituitary cells.

B. Draznin, K. Sussman, A. Vatter, 1985, Endocrinology.

Localization of somatostatin receptors in secretion vesicles in anterior pituitary cells and pancreatic islets.

S. Melmed, P. Mehler, B. Draznin, 1985, Journal of receptor research.

16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2022.

E. Huang, Sandeep R. Das, A. Peters, 2021, Diabetes care.

Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3'-kinase.

B. Draznin, J. Leitner, R. Pereira, 2008, Life sciences.

Inhibition of the phosphatidylinositol 3'-kinase signaling pathway leads to decreased insulin-stimulated adiponectin secretion from 3T3-L1 adipocytes.

B. Draznin, R. Pereira, 2005, Metabolism: clinical and experimental.

Effect of streptozotocin-induced diabetes on GLUT-4 phosphorylation in rat adipocytes.

N. Begum, B. Draznin, 1992, The Journal of clinical investigation.

Phosphatidylinositol 3-kinase redistribution is associated with skeletal muscle insulin resistance in gestational diabetes mellitus.

J. Friedman, J. Shao, H. Yamashita, 2002, Diabetes.

Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes.

J. Reusch, N. Begum, B. Draznin, 1991, Endocrinology.

Mechanism of insulin resistance induced by sustained levels of cytosolic free calcium in rat adipocytes.

D. Leroith, M. Adamo, B. Draznin, 1989, Endocrinology.

Glycemic Control in the Critically Ill Patient

B. Draznin, 2014 .

Glycemic control and outcomes of hospitalization in noncritically ill patients with type 2 diabetes admitted with cardiac problems or infections.

B. Draznin, S. Seggelke, N. Rasouli, 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Fetal hyperinsulinemia increases farnesylation of p21 Ras in fetal tissues.

M. Goalstone, B. Draznin, J. Leitner, 2001, American journal of physiology. Endocrinology and metabolism.

The Nature of Insulin Secretory Defect in Aging Rats

B. Draznin, K. Sussman, J. P. Steinberg, 1985, Diabetes.

Practical Approach to Management of Inpatient Hyperglycemia in Select Patient Populations

B. Draznin, C. Wang, 2013, Hospital practice.

Cytosolic calcium: a new factor in insulin resistance?

B. Draznin, 1991, Diabetes research and clinical practice.

Insulin signaling.

M. Goalstone, B. Draznin, M. Goalstone, 1997, The Western journal of medicine.

Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor.

J. Olefsky, A. Saltiel, D. Rose, 1994, The Journal of biological chemistry.

Insulin, Cation Metabolism and Insulin Resistance

J. Sowers, B. Draznin, 1998, Journal of basic and clinical physiology and pharmacology.

Somatostatin inhibits fusion of pituitary secretion vesicles with the plasma membranes.

B. Draznin, K. Sussman, N. Sherman, 1986, Biochemical and biophysical research communications.

Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver.

B. Draznin, D. Schalch, U. Heinrich, 1979, Endocrinology.

Inhibition of intracellular proteolysis by insulin in isolated rat hepatocytes. Possible role of internalized hormone.

B. Draznin, M. Trowbridge, 1982, The Journal of biological chemistry.

Effect of Diabetes on Cytosolic Free Ca2+ and Na+-K+-ATPase in Rat Aorta

B. Draznin, K. Sussman, Takeshi Ohara, 1991, Diabetes.

Insulin and glucose modulate protein kinase C activity in rat adipocytes.

B. Draznin, J. Leitner, K. Sussman, 1988, Biochemical and biophysical research communications.

Insulin Regulation of Sterol Regulatory Element-binding Protein-1 Expression in L-6 Muscle Cells and 3T3 L1 Adipocytes*

K. Nadeau, B. Draznin, J. Leitner, 2004, Journal of Biological Chemistry.

Role of cAMP in mediating effects of fasting on dephosphorylation of insulin receptor.

N. Begum, B. Draznin, K. Sussman, 1992, The American journal of physiology.

Na+/K(+)-ATPase activity and its alpha II subunit gene expression in rat skeletal muscle: influence of diabetes, fasting, and refeeding.

K. Kawakami, B. Draznin, K. Sussman, 1992, Metabolism: clinical and experimental.

Signal transduction pathways leading to insulin-induced early gene induction.

J. Olefsky, A. Saltiel, B. Jhun, 1995, Biochemistry.

Differential Effects of Diabetes on Adipocyte and Liver Phosphotyrosine and Phosphoserine Phosphatase Activities

N. Begum, B. Draznin, K. Sussman, 1991, Diabetes.

Insulin and Glyburide Increase Cytosolic Free-Ca2+ Concentration in Isolated Rat Adipocytes

B. Draznin, K. Sussman, M. Kao, 1987, Diabetes.

Evidence that p21ras mediates the neurotrophic effects of insulin and insulin-like growth factor I in chick forebrain neurons.

K. Heidenreich, B. Draznin, W. Leitner, 1994, Endocrinology.

Cyclosporin-induced inhibition of insulin release. Possible role of voltage-dependent calcium transport channels.

B. Draznin, J. Leitner, S. Metz, 1988, Biochemical pharmacology.

Insulin stimulates the phosphorylation and activity of farnesyltransferase via the Ras-mitogen-activated protein kinase pathway.

M. Goalstone, B. Draznin, K. Carel, 1997, Endocrinology.

Effect of insulin on farnesyltransferase gene transcription and mRNA stability.

M. Goalstone, B. Draznin, 1999, Biochemical and biophysical research communications.

Insulin Promotes Phosphorylation and Activation of Geranylgeranyltransferase II

Y. Le Marchand-Brustel, M. Cormont, M. Goalstone, 1999, The Journal of Biological Chemistry.

Effect of Dietary Macronutrient Composition on AMPK and SIRT1 Expression and Activity in Human Skeletal Muscle

M. Cornier, B. Draznin, J. Leitner, 2012, Hormone and Metabolic Research.

Insulin-induced Adipocyte Differentiation

P. Watson, J. Reusch, A. Nesterova, 2001, The Journal of Biological Chemistry.

Functional interactions of phosphatidylinositol 3-kinase with GTPase-activating protein in 3T3-L1 adipocytes

J. Reusch, B. Draznin, K. Carel, 1996, Molecular and cellular biology.

Early growth response gene-1 expression in vascular smooth muscle cells effects of insulin and oxidant stress.

B. Draznin, G. Sharma, C. Wang, 2006, American journal of hypertension.

Glyburide increases cytosolic-free calcium concentrations in normal rat pancreatic islet cells.

B. Draznin, J. Leitner, S. Metz, 1988, Metabolism: clinical and experimental.

Increased farnesylation of p21-Ras and neonatal macrosomia in women with gestational diabetes.

J. Chappell, B. Draznin, J. Leitner, 2006, The Journal of pediatrics.

Human placental growth hormone causes severe insulin resistance in transgenic mice.

J. Friedman, A. Bartke, J. Shao, 2002, American journal of obstetrics and gynecology.

Pilot study of using neutral protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes.

B. Draznin, S. Seggelke, Joanna Gibbs, 2011, Journal of hospital medicine.

Diabetes and atherosclerosis: Molecular basis and clinical aspects

R. Eckel, B. Draznin, 1993 .

Multiple Disease Associations in Autoimmune Polyglandular Syndrome Type II.

B. Draznin, A. Michels, Amita Maturu, 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Molecular Biology of Diabetes

D. Leroith, B. Draznin, 1994, Humana Press.

Cytosolic calcium and insulin resistance in elderly patients with essential hypertension.

B. Draznin, W. Mitchell, R. Byyny, 1992, American journal of hypertension.

Summary of Revisions: Standards of Medical Care in Diabetes-2022.

E. Huang, Sandeep R. Das, A. Peters, 2021, Diabetes care.

Effect of diphenylhydantoin on patterns of insulin secretion in obese subjects

B. Draznin, D. Ayalon, L. Laurian, 2007, Acta diabetologia latina.

Molecular and cellular biology of diabetes mellitus

D. Leroith, S. Melmed, B. Draznin, 1989 .

Insulin and insulin-like growth factor-I signal transduction requires p21ras.

J. Olefsky, B. Jhun, J. Meinkoth, 1994, The Journal of biological chemistry.

Interactions of Protein Kinase C with Insulin Signaling

B. Draznin, K. Carel, W. Leitner, 1996, The Journal of Biological Chemistry.

Transition of Patients to and from Insulin Degludec: A Clinical Challenge.

I. Hirsch, B. Draznin, 2019, The Journal of clinical endocrinology and metabolism.

Insulin signaling network -- waiting for Copernicus.

B. Draznin, 1996, Endocrinology.

INSULIN‐LIKE GROWTH FACTOR AND ITS CARRIER PROTEIN IN HYPOPITUITARY AND HYPOTHYROID CHILDREN AND ADULTS

B. Draznin, D. Schalch, U. Heinrich, 1980, Clinical endocrinology.

GLUT-4 phosphorylation and its intrinsic activity. Mechanism of Ca(2+)-induced inhibition of insulin-stimulated glucose transport.

J. Reusch, N. Begum, B. Draznin, 1993, The Journal of biological chemistry.

In Vivo Knockdown of p85α with an Antisense Oligonucleotide Improves Insulin Sensitivity in Lep ob/ob and Diet-induced Obese Mice

J. Friedman, B. Draznin, J. Leitner, 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Somatostatin Receptors in Endocrine Cells

B. Draznin, 1985 .

The effect of hypothyroidism on growth, serum growth hormone, the growth hormone-dependent somatomedin, insulin-like growth factor, and its carrier protein in rats.

B. Draznin, D. Schalch, C. J. Johnson, 1979, Endocrinology.

Hyperinsulinemia potentiates activation of p21Ras by growth factors.

M. Goalstone, B. Draznin, K. Carel, 1997, Endocrinology.

Differential Requirement for p21ras Activation in the Metabolic Signaling by Insulin

J. Reusch, B. Draznin, K. Carel, 1995, The Journal of Biological Chemistry.

Exocytosis in normal anterior pituitary cells. Quantitative correlation between growth hormone release and the morphological features of exocytosis.

B. Draznin, K. Sussman, N. Sherman, 1988, The Journal of clinical investigation.

Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance.

K. Iida, J. Friedman, J. Kopchick, 2007, Diabetes.

Effect of Insulin on Farnesyltransferase

D. Accili, K. Rother, M. Goalstone, 1998, The Journal of Biological Chemistry.

Unmasking of arachidonate-induced insulin release by removal of extracellular calcium. Arachidonic acid mobilizes cellular calcium in rat islets of Langerhans.

B. Draznin, J. Leitner, S. Metz, 1987, Biochemical and biophysical research communications.

Measurement of cytosolic free calcium concentration in relation to insulin release in normal rat pancreatic islets.

B. Draznin, J. Leitner, S. Metz, 1987, Diabetes research and clinical practice.

Involvement of ErbB2 in the Signaling Pathway Leading to Cell Cycle Progression from a Truncated Epidermal Growth Factor Receptor Lacking the C-terminal Autophosphorylation Sites (*)

J. Olefsky, A. Saltiel, D. Rose, 1996, The Journal of Biological Chemistry.

Cytosolic Free-Calcium Concentrations in Normal Pancreatic Islet Cells: Effect of Secretagogues and Somatostatin

B. Draznin, J. Leitner, K. Sussman, 1987, Diabetes.

Insulin inhibits dephosphorylation of adenosine 3',5'-monophosphate response element-binding protein/activating transcription factor-1: effect on nuclear phosphoserine phosphatase-2a.

J. Reusch, B. Draznin, P. Hsieh, 1994, Endocrinology.

Calcium-induced inhibition of phosphoserine phosphatase in insulin target cells is mediated by the phosphorylation and activation of inhibitor 1.

N. Begum, B. Draznin, K. Sussman, 1992, The Journal of biological chemistry.

The effect of renal impairment on growth in the rat: relationship to malnutrition and serum somatomedin levels.

B. Draznin, D. Schalch, C. Emler, 1981, Endocrinology.

Inpatient management of diabetes and hyperglycemia

B. Draznin, S. Seggelke, 2013 .

Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation.

J. Olefsky, T. Sasaoka, W. J. Langlois, 1994, The Journal of biological chemistry.

The endocrine secretion granule revisited- postulating new functions.

P. Mehler, B. Draznin, J. Leitner, 1982, Metabolism: clinical and experimental.

12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes-2022.

E. Huang, Sandeep R. Das, A. Peters, 2021, Diabetes care.

5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2022.

E. Huang, Sandeep R. Das, A. Peters, 2021, Diabetes care.

6. Glycemic Targets: Standards of Medical Care in Diabetes-2022.

E. Huang, Sandeep R. Das, A. Peters, 2021, Diabetes care.

In vivo administration of interleukin-1 inhibits glucose-stimulated insulin release.

B. Draznin, K. Lafferty, K. Sussman, 1989, Diabetes research and clinical practice.

Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways.

B. Draznin, I. Gurevich, C. Wang, 2003, Diabetes.

Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells.

P. Watson, M. Brownlee, M. Goalstone, 2000, Circulation research.

Garlic extract methylallyl thiosulfinate blocks insulin potentiation of platelet-derived growth factor-stimulated migration of vascular smooth muscle cells.

B. Draznin, Chul-hak Yang, M. Goalstone, 2003, Metabolism: clinical and experimental.

Enhanced insulin signaling via Shc in human breast cancer.

J. Chappell, T. Ciaraldi, B. Draznin, 2003, Metabolism: clinical and experimental.

Hep-G2 glucose transporter gene polymorphism in Caucasian, black, Hispanic and Japanese patients with NIDDM.

B. Draznin, K. Sussman, J. Wilk, 1990, Diabetes research and clinical practice.

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022.

E. Huang, A. Peters, J. Reusch, 2021, Diabetes care.

Molecular Mechanisms of Insulin Resistance: Serine Phosphorylation of Insulin Receptor Substrate-1 and Increased Expression of p85α

B. Draznin, 2006, Diabetes.

Molecular mechanisms of insulin resistance that impact cardiovascular biology.

B. Draznin, M. Goalstone, C. Wang, 2004, Diabetes.

Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle.

J. Friedman, J. Shao, L. Qiao, 2004, Endocrinology.

Inhibition of Phosphatidylinositol 3-Kinase Enhances Mitogenic Actions of Insulin in Endothelial Cells*

M. Quon, G. Koh, B. Draznin, 2002, The Journal of Biological Chemistry.

Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals

D. Moller, N. Ruderman, J. Ivy, 1999, Diabetologia.

Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells.

J. Sowers, R. Natarajan, M. Goalstone, 1998, Endocrinology.

Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action

B. Draznin, S. Inzucchi, S. Golden, 2013, Diabetes Care.

Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase.

B. Draznin, J. Leitner, R. Adochio, 2009, Endocrinology.

Potentiation of Rho-A-mediated Lysophosphatidic Acid Activity by Hyperinsulinemia*

J. Chappell, B. Draznin, J. Leitner, 2000, The Journal of Biological Chemistry.

8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2022.

E. Huang, A. Peters, J. Reusch, 2021, Diabetes care.

Older Adults

E. Huang, Sandeep R. Das, A. Peters, 2021, The Maudsley Trainee Guide to the CASC.

3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022.

E. Huang, A. Peters, J. Reusch, 2021, Diabetes care.

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2022.

E. Huang, Sandeep R. Das, A. Peters, 2021, Diabetes care.

Insulin action, effects on gene expression and regulation, and glucose transport

D. Leroith, B. Draznin, 1994 .

skeletal muscle SREBP-1 expression and intramuscular triglyceride in Exercise training and calorie restriction increase

K. Nadeau, J. Reusch, B. Draznin, 2016 .

Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle.

K. Nadeau, J. Reusch, B. Draznin, 2006, American journal of physiology. Endocrinology and metabolism.

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022.

E. Huang, Sandeep R. Das, A. Peters, 2021, Diabetes care.

Mechanism of the mitogenic influence of hyperinsulinemia

B. Draznin, 2011, Diabetology & metabolic syndrome.

USE OF NPH INSULIN FOR GLUCOCORTICOID-INDUCED HYPERGLYCEMIA.

B. Draznin, Cecilia C. Low Wang, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.

B. Draznin, S. Seggelke, N. Rasouli, 2012, The Journal of clinical endocrinology and metabolism.

Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy.

B. Draznin, S. Seggelke, N. Rasouli, 2011, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

Transitional Care Clinic for Uninsured and Medicaid-Covered Patients With Diabetes Mellitus Discharged From the Hospital: A Pilot Quality Improvement Study

B. Draznin, S. Seggelke, N. Rasouli, 2014, Hospital practice.

Insulin Signals to Prenyltransferases via the Shc Branch of Intracellular Signaling*

J. Olefsky, P. Berhanu, Prem M. Sharma, 2001, The Journal of Biological Chemistry.

THE IMPACT OF CARDIOVASCULAR DRUGS ON GLYCEMIC CONTROL: A REVIEW.

S. Arnold, B. Draznin, M. Kosiborod, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Insulin sensitivity determines the effectiveness of dietary macronutrient composition on weight loss in obese women.

R. Eckel, J. Hill, M. Cornier, 2005, Obesity research.

Atherosclerosis in diabetes and insulin resistance

B. Draznin, J. Reusch, 2007, Diabetes, obesity & metabolism.

Role of the liver in regulating somatomedin activity: effects of streptozotocin diabetes and starvation on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver.

B. Draznin, D. Schalch, L. L. Miller, 1981, Endocrinology.

Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

J. Halter, A. Sinclair, I. Hirsch, 2019, The Journal of clinical endocrinology and metabolism.

Quantitative studies of the rate of insulin internalization in isolated rat hepatocytes.

B. Draznin, M. Trowbridge, L. Ferguson, 1984, Biochemical Journal.

Knockdown of JNK rescues 3T3-L1 adipocytes from insulin resistance induced by mitochondrial dysfunction.

B. Draznin, R. Adochio, Toni J Kim, 2009, Biochemical and biophysical research communications.

Low-Carbohydrate Diets in the Treatment of the Metabolic Syndrome

M. Cornier, B. Draznin, 2013 .

11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022.

E. Huang, Sandeep R. Das, A. Peters, 2021, Diabetes care.

7. Diabetes Technology: Standards of Medical Care in Diabetes-2022.

E. Huang, Sandeep R. Das, A. Peters, 2021, Diabetes care.

1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2022.

E. Huang, Sandeep R. Das, A. Peters, 2021, Diabetes care.

Acute effects of different diet compositions on skeletal muscle insulin signalling in obese individuals during caloric restriction.

M. Cornier, B. Draznin, J. Leitner, 2013, Metabolism: clinical and experimental.

Time to Follow the Evidence: Glycemic control and cardiovascular benefits of new diabetes medications.

I. Hirsch, B. Draznin, 2021, The American journal of medicine.

Multiple abnormalities of myocardial insulin signaling in a porcine model of diet-induced obesity.

B. Bergman, B. Draznin, J. Leitner, 2010, American journal of physiology. Heart and circulatory physiology.

Clinical Research in Diabetes and Obesity

B. Draznin, R. Rizza, Robert Rizza, 1997, Contemporary Biomedicine.

Decreased Insulin Binding and Degradation Associated with Depressed Intracellular ATP Content

B. Draznin, D. Schalch, K. Sussman, 1980, Diabetes.

Cytosolic calcium and insulin resistance.

B. Draznin, Boris Draznin, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity.

J. Regensteiner, K. Nadeau, J. Reusch, 2009, The Journal of clinical endocrinology and metabolism.

Increasing Dietary Fat Elicits Similar Changes in Fat Oxidation and Markers of Muscle Oxidative Capacity in Lean and Obese Humans

W. Gozansky, E. Melanson, P. MacLean, 2012, PloS one.

Molecular Mechanisms of Insulin Resistance

B. Draznin, 2019, Contemporary Endocrinology.

Early responses of insulin signaling to high-carbohydrate and high-fat overfeeding

M. Cornier, B. Draznin, J. Leitner, 2009, Nutrition & metabolism.

Inverse relationship between GLUT-4 phosphorylation and its intrinsic activity.

J. Reusch, B. Draznin, K. Sussman, 1993, The Journal of biological chemistry.

Intensive Control of Diabetes in the Hospital: Why, How, and What is in the Future?

B. Draznin, Elisa Hsia, 2011, Journal of diabetes science and technology.

Discordance between intramuscular triglyceride and insulin sensitivity in skeletal muscle of Zucker diabetic rats after treatment with fenofibrate and rosiglitazone

K. Nadeau, B. Draznin, B Draznin, 2007, Diabetes, obesity & metabolism.

Protein phosphatase-1 and -2a activities in cultured fetal chick neurons: differential regulation by insulin and insulin-like growth factor-I.

K. Heidenreich, N. Begum, B. Draznin, 1993, Endocrinology.

Insulin activates p21Ras and guanine nucleotide releasing factor in cells expressing wild type and mutant insulin receptors.

J. Olefsky, Y. Takata, B. Draznin, 1993, The Journal of biological chemistry.

Response to Comment on: Draznin et al. Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action. Diabetes Care 2013;36:1807–1814

B. Draznin, S. Inzucchi, S. Golden, 2013, Diabetes Care.

Effects of chronic hyperinsulinemia in insulin-resistant patients

S. Muntoni, B. Draznin, Sergio Muntoni, 2008, Current diabetes reports.

Mechanisms of the fasting-induced dissociation of insulin binding from its action in isolated rat hepatocytes

N. Begum, B. Draznin, N. Neufeld, 1984, Molecular and Cellular Biochemistry.

Guidelines Versus Guidelines: What's Best for the Patient?

D. Nathan, W. Cefalu, B. Draznin, 2018, Annals of Internal Medicine.

Mechanism of impaired metabolic signaling by a truncated human insulin receptor. Decreased activation of protein phosphatase 1 by insulin.

J. Olefsky, N. Begum, B. Draznin, 1993, The Journal of biological chemistry.

Relationship between cytosolic free calcium concentration and 2-deoxyglucose uptake in adipocytes isolated from 2- and 12-month-old rats.

B. Draznin, K. Sussman, N. Sherman, 1988, Endocrinology.

Nutritional upregulation of p85α expression is an early molecular manifestation of insulin resistance

M. Cornier, D. Bessesen, B. Draznin, 2006, Diabetologia.

Energy-dependent steps in insulin-hepatocyte interaction.

B. Draznin, K. Sussman, C. Solomons, 1981, Endocrinology.

Do we need to broaden the scope of inpatient diabetes education to include our faculty?

B. Draznin, Richard Hellman, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia.

D. Accili, M. Reitman, J. Olefsky, 2000, Endocrinology.

Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

J. Halter, A. Sinclair, I. Hirsch, 2019, The Journal of clinical endocrinology and metabolism.

11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022.

E. Huang, Sandeep R. Das, A. Peters, 2021, Diabetes care.

15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022.

E. Huang, A. Peters, J. Reusch, 2021, Diabetes care.

Clinical Diabetes Centers of Excellence: A Model for Future Adult Diabetes Care

D. Harlan, I. Hirsch, R. Gabbay, 2018, The Journal of clinical endocrinology and metabolism.